Sector valuations Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 234.24 CHF | +0.11% |
|
-1.18% | - |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 33.15x | 4.43x | 1.24x | 5.95x | 17.82x | 24.93x | 0.98% | 48.93B | ||
| -21.5x | 22.2x | -0.33x | 245.64x | -23.19x | -21.81x | -.--% | 45.01B | ||
| 34.48x | 6.3x | -36.03x | 3.33x | 14.35x | 21.68x | -.--% | 44.07B | ||
| 46.93x | 7.94x | 0.23x | 5.41x | 29.72x | 34.2x | -.--% | 40.73B | ||
| 28.42x | 2.31x | 0.58x | 8.6x | 21.8x | 25.89x | 0.4% | 33.52B | ||
| 33.62x | 24.12x | 2.23x | 5.51x | 25.02x | 26.17x | -.--% | 16.5B | ||
| 24.24x | 2.71x | 0.7x | 2.11x | 9.11x | 14.11x | 1.11% | 14.67B | ||
| 77.18x | 4.57x | -0.34x | 4.06x | 15.75x | 19.35x | -.--% | 13.77B | ||
| 27.98x | 1.33x | 0.27x | 1.85x | 11.36x | 12.93x | -.--% | 12.72B | ||
| -46x | 23.7x | 123.08x | 7.63x | 186.93x | -2486.48x | -.--% | 11.66B | ||
| 52.42x | 4.57x | 2.74x | 8.7x | 24.69x | 29.45x | 0.44% | 11.36B | ||
| -27.52x | 8.1x | 1.04x | 107.16x | -30.5x | -53.08x | -.--% | 10.61B | ||
| 37.96x | 4.36x | 2.45x | 4.5x | 19.48x | 30.97x | 0.59% | 10.39B | ||
| -25.33x | 8.75x | -8.29x | 10575.2x | -20.89x | -20.57x | -.--% | 9.82B | ||
| -30.32x | 8.81x | -6.14x | 80.33x | -20.25x | -19.64x | -.--% | 9.76B | ||
| -15.96x | 672.49x | -0.3x | 10.46x | -16.79x | -16.16x | -.--% | 9.65B | ||
| 31.33x | - | -0.1x | 16.4x | 29.92x | 29.23x | -.--% | 9.43B | ||
| 22.57x | 2.4x | -32.17x | 4.51x | 12.06x | 15.41x | 0.31% | 8.99B | ||
| Average | 15.76x | 47.59x | 2.83x | 616.52x | 17.02x | -129.63x | 0.21% | 20.09B | |
| Weighted average by Cap. | 20.27x | 27.14x | -1.10x | 327.78x | 15.14x | -67.78x | 0.25% |
Select your edition
All financial news and data tailored to specific country editions
















